Oncoliq is transforming cancer detection with a groundbreaking, low-cost, non-invasive test that identifies multiple cancers early using proprietary technology. By analyzing tumor type-specific circulating miRNAs on PCR equipment, Oncoliq offers an unparalleled approach to precision detection, enabling timely diagnosis and intervention. This revolutionary method holds the potential to save millions of lives lost each year to undetected cancer.

Limay Biosciences harnesses cutting-edge technology to create hyperlocal molecular testing solutions. By combining highly sensitive isothermal amplification with precise CRISPR-Cas-based target recognition, their portable, battery-operated point-of-care devices can detect virtually any DNA or RNA target. Limay Biosciences is committed to making precise diagnostic testing accessible to everyone, anywhere, and at any time.

MultiplAI Health is developing the world’s best biomarker product for cardiac disease. It is a preventive healthcare insights company, pioneering RNA-based blood screening for complex diseases. Their proprietary technology uses genomic sequencing to digitize a whole blood sample, and advanced Artificial Intelligence to transform it into a detailed, actionable health assessment. MultiplAI’s technology is already able to detect subclinical disease better than clinical standards by as much as 35%. Their precise analysis will enable proactive health management to enhance longevity at scale.

TELL offers a scalable, non-invasive approach to brain health assessment. Their AI-assisted speech analysis technology provides real-time insights into brain function, empowering pharmaceutical research, individuals, and healthcare professionals to make informed decisions using any device with a mic.

Dharma is poised to transform the lives of individuals with osteoarthritis through a novel, non-invasive approach using precision-delivered modified microRNAs. These microRNAs promote chondrocyte reprogramming, inducing long-term tissue regeneration in a cost-efficient manner.

Exomas develops formulations based on native exosomes capable of preventing and treating neurodegenerative diseases. Exomas promotes neurogenesis and neuroplasticity by stimulating the differentiation of neural stem cells.

1.7 million critical bone injuries per year have no therapeutic options today. To solve this, MesencHyal-T is developing stem cell products capable of regenerating bones naturally. With a single intervention, it reduces treatment and bone recovery time, as well as complications.

Libera is pioneering the fight against inflammatory diseases through precision medicine, utilizing the innovative functionalization of extracellular vesicles. By tailoring treatments to individual patient needs, Libera offers a groundbreaking solution to address the diverse and complex challenges of these conditions.

Spectrum pioneers innovative therapies to enhance the quality of life for patients with acute and chronic liver diseases. By developing a range of tailored molecules, they provide personalized and highly effective therapeutic solutions.

Biotalife is making possible to screen our skin microbiome, paving the way for precision skin care, offering a solution to each need and skin type.

Pill.AR revolutionizes wellness and pharmaceuticals with personalized supplements and medications using state-of-the-art additive manufacturing. Their decentralized production system ensures precise customization, distinguishing them in the industry.

Gameet recognizes the challenges posed by traditional assisted fertilization techniques, which often result in low success rates and impose significant emotional and financial burdens on patients. Their mission is to revolutionize artificial reproduction by harnessing the power of 3D printing technology. By developing innovative, customized devices, Gameet aims to enhance the effectiveness and accessibility of fertility treatments, ultimately making the journey to parenthood a more hopeful and affordable experience for all involved.